[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100604288":3},{"organization":4,"armGroups":7,"interventions":13,"overallOfficials":10,"centralContacts":19,"locations":25,"responsibleParty":67,"collaborators":69,"id":72,"slug":73,"hasResults":74,"nctId":75,"briefTitle":76,"officialTitle":77,"acronym":10,"eligibilityCriteria":78,"healthyVolunteers":74,"sex":79,"minAge":10,"maxAge":10,"enrollmentInfo":80,"targetDuration":83,"studyType":84,"phases":10,"briefSummary":85,"conditions":86,"keywords":10,"overallStatus":28,"whyStopped":10,"lastUpdateSubmitDate":89,"lastUpdatePostDateStruct":90,"startDateStruct":93,"completionDateStruct":95,"leadSponsor":97,"locationsCount":98},{"fullName":5,"class":6},"W.L.Gore & Associates","INDUSTRY",[8],{"label":9,"type":10,"description":10,"interventionNames":11},"TAMBE",null,[12],"Device: GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis",[14],{"type":15,"name":16,"description":17,"armGroupLabels":18,"otherNames":10},"DEVICE","GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis","The target patients are those who were attempted to implant the AC during the enrollment period of this surveillance. Patients will also be targeted even if all components of the TAMBE device (devices that can be used in combination with AC specified in IFU) were not used, or if a device other than the component of the TAMBE device was used.",[9],[20],{"name":21,"role":22,"phone":23,"phoneExt":10,"email":24},"Katsuyuki Niwa","CONTACT","+819017754499","kniwa@wlgore.com",[26,38,46,54,59],{"facility":27,"status":28,"city":29,"state":10,"zip":10,"country":30,"countryCode":31,"cosmosGeoPoint":32,"geoPoint":37,"contacts":10},"The Jikei University Hospital","RECRUITING","Minatoku","Japan","JP",{"type":33,"coordinates":34},"Point",[35,36],130.59341,32.57237,{"lat":36,"lon":35},{"facility":39,"status":28,"city":40,"state":10,"zip":10,"country":30,"countryCode":31,"cosmosGeoPoint":41,"geoPoint":45,"contacts":10},"Nagoya University Hospital","Nagoya",{"type":33,"coordinates":42},[43,44],136.90641,35.18147,{"lat":44,"lon":43},{"facility":47,"status":28,"city":48,"state":10,"zip":10,"country":30,"countryCode":31,"cosmosGeoPoint":49,"geoPoint":53,"contacts":10},"Morinomiya Hospital","Osaka",{"type":33,"coordinates":50},[51,52],135.50107,34.69379,{"lat":52,"lon":51},{"facility":55,"status":28,"city":48,"state":10,"zip":10,"country":30,"countryCode":31,"cosmosGeoPoint":56,"geoPoint":58,"contacts":10},"Osaka International Medical & Science Center Osaka Police Hospital",{"type":33,"coordinates":57},[51,52],{"lat":52,"lon":51},{"facility":60,"status":28,"city":61,"state":10,"zip":10,"country":30,"countryCode":31,"cosmosGeoPoint":62,"geoPoint":66,"contacts":10},"The University of Osaka Hospital","Suita",{"type":33,"coordinates":63},[64,65],135.51567,34.76143,{"lat":65,"lon":64},{"type":68,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[70],{"name":71,"class":6},"CMIC Co, Ltd. Japan","100604288","tambe-japan-post-marketing-surveillance-100604288",false,"NCT07147569","TAMBE Japan Post-Marketing Surveillance","GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis Post-Marketing Surveillance","Inclusion Criteria:\n\n* Patients who were attempted to implant the AC\n* Thoracoabdominal aortic aneurysm\n* Pararenal abdominal aortic aneurysm\n\nExclusion Criteria:\n\n* N\u002FA","ALL",{"count":81,"type":82},100,"ESTIMATED","60 Months","OBSERVATIONAL","To evaluate the safety and efficacy of multi component system (TAMBE device) including GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis (Aortic Component; AC) under post-marketing use.",[87,88],"Thoracoabdominal Aortic Aneurysm","Pararenal Aortic Aneurysm","2026-05-04",{"date":91,"type":92},"2026-05-05","ACTUAL",{"date":94,"type":92},"2026-03-27",{"date":96,"type":82},"2034-02-28",{"name":5,"class":6},5]